Collection: Lucius Pharmaceuticals
-
Sotolacizumab is indicated for the treatment of adult patients with KRAS G12C mutant locally advanced or metastatic non-small cell lung cancer who have received at least one prior systemic therapy.
Regular price ¥1,700.00 CNYRegular priceUnit price / per¥2,800.00 CNYSale price ¥1,700.00 CNYSale -
Gilteritinib is used to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) and FLT3.
Regular price ¥2,100.00 CNYRegular priceUnit price / per¥3,200.00 CNYSale price ¥2,100.00 CNYSale -
Deuterocelexin is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Regular price ¥320.00 CNYRegular priceUnit price / per¥500.00 CNYSale price ¥320.00 CNYSale -
Ensidipine is used to treat acute myeloid leukemia (AML) in adults with an IDH2 mutation.
Regular price ¥1,350.00 CNYRegular priceUnit price / per¥2,500.00 CNYSale price ¥1,350.00 CNYSale -
LuciVos IVOSIDENIB 250 MG 60'S Approval No. 07 L 0988/23 Expiry Date 20-7-2026
Regular price ¥4,000.00 CNYRegular priceUnit price / per¥7,000.00 CNYSale price ¥4,000.00 CNYSale -
Eltrombopag 25 mg is used to treat thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura.
Regular price ¥260.00 CNYRegular priceUnit price / per¥800.00 CNYSale price ¥260.00 CNYSale -
Tazepam Tazepam is a methyltransferase inhibitor indicated for the treatment of: • Adults and pediatric patients 16 years and older with metastatic or locally advanced epithelioid sarcoma who are not candidates for complete resection.
Regular price ¥4,900.00 CNYRegular priceUnit price / per¥8,800.00 CNYSale price ¥4,900.00 CNYSale -
Selumetinib 10 mg is indicated for patients aged 2 years and older with neurofibromatosis type 1 (NF1) and inoperable pelvic neurofibromas.
Regular price ¥1,800.00 CNYRegular priceUnit price / per¥2,800.00 CNYSale price ¥1,800.00 CNYSale -
Lipivir is indicated for the treatment of severe alopecia areata in adolescents and adults aged 12 years and above.
Regular price ¥650.00 CNYRegular priceUnit price / per¥1,200.00 CNYSale price ¥650.00 CNYSale -
Avatrombopag for the treatment of thrombocytopenia (low platelets) in adults with chronic liver disease who are planning surgery.
Regular price ¥400.00 CNYRegular priceUnit price / per¥1,000.00 CNYSale price ¥400.00 CNYSale -
Semaglutide 7mg Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for use in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Regular price ¥550.00 CNYRegular priceUnit price / per¥980.00 CNYSale price ¥550.00 CNYSale -
Pratinib is used to treat adult patients with advanced RET fusion-positive non-small cell lung cancer;
Regular price ¥3,300.00 CNYRegular priceUnit price / per¥5,800.00 CNYSale price ¥3,300.00 CNYSale -
Olaparib is indicated for advanced ovarian cancer with germline BRCA mutations
Regular price ¥1,200.00 CNYRegular priceUnit price / per¥2,500.00 CNYSale price ¥1,200.00 CNYSale -
Semaglutide 14mg Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for use in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Regular price ¥840.00 CNYRegular priceUnit price / per¥1,800.00 CNYSale price ¥840.00 CNYSale -
Trametinib is indicated as a single agent or in combination with dabrafenib for the treatment of patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations.
Regular price ¥900.00 CNYRegular priceUnit price / per¥1,700.00 CNYSale price ¥900.00 CNYSale -
Adalacilib is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have received at least one prior systemic therapy.
Regular price ¥3,300.00 CNYRegular priceUnit price / per¥6,000.00 CNYSale price ¥3,300.00 CNYSale